Altria Group, Inc.

Altria Group, Inc.

CIK 764180 · SEC EDGAR पर देखें ↗

कार्यकर्ता

पहला एसईसी फाइलिंग: 7 फ़रवरी 2025 · नवीनतम: 7 फ़रवरी 2025

इस पृष्ठ पर

Altria Group, Inc. is an American corporation and one of the world's largest producers and marketers of tobacco, cigarettes, and medical products in the treatment of illnesses caused by tobacco. It operates worldwide and is headquartered in the city of Richmond, Virginia.

और पढ़ें

Altria Group, Inc. is an American corporation and one of the world's largest producers and marketers of tobacco, cigarettes, and medical products in the treatment of illnesses caused by tobacco. It operates worldwide and is headquartered in the city of Richmond, Virginia.

Altria is the parent company of Philip Morris USA, John Middleton, Inc., U.S. Smokeless Tobacco Company, Inc., Philip Morris Capital Corporation, and NJOY Holdings, Inc. Altria also maintains large minority stakes in Belgium-based brewer AB InBev and the Canadian cannabis company Cronos Group. It is a component of the S&P 500 and was a component of the Dow Jones Industrial Average from 1985 to 2008, dropping due to spin-offs of Kraft Foods Inc. in 2007 and Philip Morris International in 2008.

A study published in Science Advances in 2024 found that Altria was responsible for 2% of global branded plastic pollution (by count), which was the 5th highest share of branded plastic pollution globally.

History

Altria emerged from Philip Morris USA. The onset of "rebranding" of Philip Morris Companies to Altria took place in 2003 (Philip Morris would later split, with Philip Morris USA remaining Altria's primary and only consistently held asset). According to Altria, it was created because Philip Morris wished to emphasize that its business portfolio had come to consist of more than Philip Morris USA and Philip Morris International; at the time, it owned an 84% stake in Kraft Foods, although that business has since been spun off. The name "Altria" is claimed to come from the Latin word for "high" and was part of a trend of companies rebranding to names that previously did not exist, Accenture (previously Andersen Consulting) and Verizon being notable examples, though linguist Steven Pinker suggests that in fact the name is an "egregious example" of phonesthesia—with the company attempting to "switch its image from bad people who sell addictive carcinogens to a place or state marked by altruism and other lofty values".

The company's branding consultants, the Wirthlin Group, said: "The name change alternative offers the possibility of masking the negatives associated with the tobacco business", thus enabling the company to improve its image and raise its profile without sacrificing tobacco profits. Philip Morris executives thought a name change would insulate the larger corporation and its other operating companies from the political pressures on tobacco.

The rebranding took place amidst social, legal, and financially troubled circumstances. In 2003 Altria was ranked Fortune number 11, and has steadily declined since. In 2010 Altria Group (MO) ranked at Fortune number 137, whereas its former asset, Philip Morris International, was ranked 94th.

In 2006, a United States court found that Philip Morris "publicly ... disputed scientific findings linking smoking and disease knowing their assertions were false." In a 2006 ruling, a federal court found that Altria, along with R. J. Reynolds, Lorillard and Philip Morris were found guilty of misleading the public about the dangers of smoking. Within this ruling, it was noted that "defendants altered the chemical form of nicotine delivered in mainstream cigarette smoke for the purpose of improving nicotine transfer efficiency and increasing the speed with which nicotine is absorbed by smokers." This was done by manipulating smoke pH with ammonia. Adding ammonia increases the smoke pH, in a process called "freebasing" which causes smokers to be "exposed to higher internal nicotine doses and become more addicted to the product."

On March 30, 2007, Altria's 88.1% stake in Kraft Foods was spun off, through a distribution of the remaining stake of shares (88.1%) to Altria shareholders. That same year, Altria began selling all its shares of Philip Morris International to Altria stockholders, a spin-off that was completed on March 28, 2008. Again in 2007 the company began the acquisition of cigar manufacturer John Middleton Co. from Bradford Holdings, which was complete in 2008. After Philip Morris International spun off, the former international subsidiaries halted the purchase of tobacco from America, which was a major factor in the closing of a newly renovated plant in North Carolina, an approximately 50% reduction in manufacturing, large-scale layoffs, and induced early retirements.

In 2008, Altria officially moved its headquarters from New York City to Richmond, Virginia, after Philip Morris sold its downtown offices in New York City a decade earlier. With a few exceptions, all manufacturing, commercial, and executive employees had long been based in and around Richmond. The company is now headquartered in an unincorporated area within Henrico County, less than five miles (8.0 km) west of the city limits of Richmond and less than 10 miles (16 km) from its downtown Richmond campus.

Aside from the Philip Morris/Altria headquarters, some of their other buildings included the Altria Center for Research and Technology in downtown Richmond, their manufacturing center in South Richmond, and the adjacent operations center which began shutting down in 2007–2008, as a result of the loss of demand from Philip Morris International member companies. The layoffs beginning in 2007 affected thousands of Altria, Altria Client Services, Philip Morris USA, and contracted employees in Richmond and North Carolina.

In 2009, Altria finalized its purchase of UST Inc., whose products included smokeless tobacco (made by U.S. Smokeless Tobacco Company) and wine (made by Chateau Ste. Michelle). This ended a short era of competition between the new Marlboro smokeless tobacco products such as snus, and those produced by UST Inc.

On December 8, 2018, Altria announced its intent to acquire a 45% stake in Cronos Group for $1.8 billion.

On December 20, 2018, Altria finalized the acquisition of a 35% stake in JUUL Labs, an e-cigarette company based out of San Francisco, California, for $12.8 billion. On November 3, 2019, it was reported that Altria was taking a $4.5 billion writedown on its stake in Juul, 35% of its original value. On July 28, 2022, it was reported that Altria's investment in Juul is now worth only 5% of the original amount of $12.8 billion. Despite the losses, Altria has announced that it will continue to support Juul and avoid investing in competing products.

Altria is taking a stake in the global business of Swiss tobacco company Burger Söhne (Helix Innovations with the On! brand) for $372 million in June 2019.

Altria and Japan Tobacco announced a joint venture called Horizon Innovations LLC on October 27, 2022. Horizon, owned 75 percent by Altria and 25 percent by Japan Tobacco, intends to sell Ploom heated tobacco sticks in the United States. FDA approval was expected to take until 2025, with customers able to buy Ploom by 2027.

Altria completed the acquisition of NJOY Holdings, Inc. on June 1, 2023.

Finances

For the fiscal year 2020, Altria reported earnings of US$4.45 billion, with an annual revenue of US$26.15 billion. Altria's shares traded at over $66 per share, and its market capitalization was valued at over US$118.5 billion in October 2018. As of 2018, the company ranked 154th on the Fortune 500 list of the largest United States corporations by revenue.

Corporate governance

Board of directors

Members of the board of directors of Altria Group as of February 2013 were:

Elizabeth E. Bailey, professor emerita, the Wharton School, University of Pennsylvania

Gerald L. Baliles (2008–2019), director, Miller Center of Public Affairs at University of Virginia; former Virginia governor

Martin Barrington, chairman and chief executive officer, Altria Group, Inc.

John T. Casteen III (2010– ), president emeritus, University of Virginia

Dinyar S. Devitre (2008– ), special advisor, General Atlantic Partners, New York, NY; former SVP and CFO of Altria

Thomas F. Farrell II (2008–2021), chairman, president and CEO, Dominion Resources, Richmond, VA

Thomas W. Jones (2002– ), senior partner, TWJ Capital LLC, Stamford, CT; formerly with Citigroup, Travelers and TIAA-CREF

Debra J. Kelly-Ennis (2013– ), former president and CEO of Diageo Canada, Inc.; also formerly with RJR Nabisco, Inc., Coca-Cola, General Motors and Grand Metropolitan

W. Leo Kiely III (2011– ), retired CEO, MillerCoors LLC, Golden, CO; formerly with Frito-Lay

Kathryn B. McQuade (2012– ), retired EVP and CFO, Canadian Pacific Railway Limited; formerly with Norfolk Southern Corporation

George Muñoz (2004– ), principal, Muñoz Investment Banking Group, LLC, Washington, DC; Partner, Tobin & Muñoz, Chicago, IL; formerly Overseas Private Investment Corporation and assistant secretary of the United States Treasury Department

Nabil Y. Sakkab (2008– ), retired Senior Vice President, corporate research and development, Procter & Gamble, Cincinnati, OH

Headquarters

Prior to being based in Virginia, Philip Morris had its headquarters in Midtown Manhattan, New York City. In 2003, Philip Morris announced that it would move its headquarters to Virginia. The company said that it planned to keep around 750 employees in its former headquarters. Brendan McCormick, a spokesperson for Philip Morris, said that the company estimated that the move would save the company over $60 million each year. The company now has its head offices in an unincorporated area of Henrico County, Virginia, near Richmond. In addition, the company has a 450,000-square-foot, $350 million Center for Research and Technology located in downtown Richmond at the Virginia BioTechnology Research Park that employs approximately 600 scientists, engineers and support staff.

Diversification

Altria, like other tobacco companies, has invested in science and medical companies which develop and produce medical products for conditions caused or aggravated by smoking. As of 2024, Altria's three medical subsidiaries included the following: Cronos group (maker of recreational cannabis), Lexaria Bioscience (Developer of proprietary drug delivery technology, DehydraTECH, to improve active pharmaceutical ingredients entrance into the bloodstream) and Micreos (biotech company focused on discovering and developing recombinant proteins for chronic dermatology and oncology conditions).

It has also designed and marketed electronic cigarettes. Altria launched the MarkTen and Green Smoke brands. Both of these were discontinued in December 2018. The company returned to this market through the acquisition of NJOY.

Political influence

According to the Center for Public Integrity, Altria spent around $101 million on lobbying the United States government between 1998 and 2004, the second-highest such figure for any organization in the nation.

Altria also funded The Advancement of Sound Science Coalition which lobbied against the scientific consensus on anthropogenic climate change.

Daniel Smith, representing Altria, sits on the Private Enterprise Board of the American Legislative Exchange Council.

In 2025, Altria was one of the donors funding the White House's East Wing demolition, and planned building of a ballroom.

Controversies

In August 2006, the Altria group was found guilty of civil fraud and racketeering. The lawsuit claimed that Altria's marketing of "light" and "low tar" cigarettes constituted fraudulent misrepresentations under the Maine Unfair Trade Practices Act (MUTPA) because it deceived smokers into thinking the products are safer than regular cigarettes.

स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗

Wikidata ↗

अंदरूनी पर

अंदरूनी लेनदेन

0 खरीदे (P) 0 बेचे (S) शुद्ध: $0 + 99 गैर-खुले बाज़ार के लेन-देन नीचे पिछले 12 महीनों में, नीचे दिखाए गए लेनदेन के आधार पर

वर्तमान कोट की तुलना में मूल्य परिवर्तन, फाइलिंग के बाद से कॉर्पोरेट एक्शन्स के लिए स्प्लिट-एडजस्टेड — बेंचमार्क नहीं, एनुअलाइज्ड नहीं, साइज-वेटेड नहीं

99 अन्य फाइलिंग छिपी हुई हैं
दिनांक टिकर कोड शेयर मूल्य मूल्य बाद में स्वामित्व Δ स्वामित्व A/D बनाम अब
1 मार्च 2007 MDLZ S 1449240 $32.08 $46491619 275000000 सीधा -0.52% निपटाया हुआ 101.2% (2026-08-20 तक की कीमत)

317 लेन-देन में से नवीनतम 100 दिखा रहा है

P = खुले बाजार की खरीद · S = बिक्री · A = अनुदान/पुरस्कार · म = विकल्प अभ्यास · G = उपहार · F = कर रोकना

अंदरूनी लेन-देन कोई सिफ़ारिश नहीं हैं; बिक्री अक्सर तरलता या कर कारणों से प्रेरित होती है।

डेरिवेटिव होल्डिंग्स (फॉर्म 4 तालिका II)

विकल्प, RSU और परिवर्तनीय प्रतिभूतियां फॉर्म 4 तालिका II पर रिपोर्ट की गई हैं।

दिनांक टिकर सुरक्षा अंतर्निहित अभ्यास मूल्य समाप्ति शेयर A/D
16 फ़रवरी 2007 MDLZ Employee Stock Option (right to buy) Common Stock (890) $31.00 12 जून 2011 890 निपटाया हुआ
14 फ़रवरी 2007 MDLZ Employee Stock Option (right to buy) Common Stock (1590) $31.00 12 जून 2011 1590 निपटाया हुआ
13 फ़रवरी 2007 MDLZ Employee Stock Option (right to buy) Common Stock (970) $31.00 12 जून 2011 970 निपटाया हुआ
12 फ़रवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (3450) $31.00 12 जून 2011 3450 निपटाया हुआ
8 फ़रवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (300) $31.00 12 जून 2011 300 निपटाया हुआ
7 फ़रवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (390) $31.00 12 जून 2011 390 निपटाया हुआ
6 फ़रवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (860) $31.00 12 जून 2011 860 निपटाया हुआ
1 फ़रवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (2080) $31.00 12 जून 2011 2080 निपटाया हुआ
31 जनवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (1370) $31.00 12 जून 2011 1370 निपटाया हुआ
30 जनवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (2860) $31.00 12 जून 2011 2860 निपटाया हुआ
29 जनवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (810) $31.00 12 जून 2011 810 निपटाया हुआ
25 जनवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (650) $31.00 12 जून 2011 650 निपटाया हुआ
23 जनवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (1010) $31.00 12 जून 2011 1010 निपटाया हुआ
22 जनवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (520) $31.00 12 जून 2011 520 निपटाया हुआ
19 जनवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (100) $31.00 12 जून 2011 100 निपटाया हुआ
17 जनवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (1010) $31.00 12 जून 2011 1010 निपटाया हुआ
12 जनवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (5120) $31.00 12 जून 2011 5120 निपटाया हुआ
11 जनवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (2950) $31.00 12 जून 2011 2950 निपटाया हुआ
9 जनवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (540) $31.00 12 जून 2011 540 निपटाया हुआ
8 जनवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (1780) $31.00 12 जून 2011 1780 निपटाया हुआ
5 जनवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (100) $31.00 12 जून 2011 100 निपटाया हुआ
4 जनवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (100) $31.00 12 जून 2011 100 निपटाया हुआ
3 जनवरी 2007 MDLZ Employee Stock option (right to buy) Common Stock (100) $31.00 12 जून 2011 100 निपटाया हुआ
28 दिसमबर 2006 MDLZ Employee Stock Option (right to buy) Common Stock (360) $31.00 12 जून 2011 360 निपटाया हुआ
27 दिसमबर 2006 MDLZ Employee Stock option (right to buy) Common Stock (740) $31.00 12 जून 2011 740 निपटाया हुआ
21 दिसमबर 2006 MDLZ Employee Stock option (right to buy) Common Stock (300) $31.00 12 जून 2011 300 निपटाया हुआ
20 दिसमबर 2006 MDLZ Employee Stock option (right to buy) Common Stock (1300) $31.00 12 जून 2011 1300 निपटाया हुआ
19 दिसमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (960) $31.00 12 जून 2011 960 निपटाया हुआ
18 दिसमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (1060) $31.00 12 जून 2011 1060 निपटाया हुआ
15 दिसमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (590) $31.00 12 जून 2011 590 निपटाया हुआ
14 दिसमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (260) $31.00 12 जून 2011 260 निपटाया हुआ
13 दिसमबर 2006 MDLZ Employee stock option (right to buy) Common Stpck (960) $31.00 12 जून 2011 960 निपटाया हुआ
12 दिसमबर 2006 MDLZ Employee stock option (right to buy) Common Stpck (100) $31.00 12 जून 2011 100 निपटाया हुआ
8 दिसमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (200) $31.00 12 जून 2011 200 निपटाया हुआ
7 दिसमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (340) $31.00 12 जून 2011 340 निपटाया हुआ
4 दिसमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (970) $31.00 12 जून 2011 970 निपटाया हुआ
1 दिसमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (200) $31.00 12 जून 2011 200 निपटाया हुआ
30 नवमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (380) $31.00 12 जून 2011 380 निपटाया हुआ
27 नवमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (500) $31.00 12 जून 2011 500 निपटाया हुआ
24 नवमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (1060) $31.00 12 जून 2011 1060 निपटाया हुआ
20 नवमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (250) $31.00 12 जून 2011 250 निपटाया हुआ
17 नवमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (810) $31.00 12 जून 2011 810 निपटाया हुआ
7 नवमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (930) $31.00 12 जून 2011 930 निपटाया हुआ
30 अक्टूबर 2006 MDLZ Employee stock option (right to buy) Common Stock (660) $31.00 12 जून 2011 660 निपटाया हुआ
27 अक्टूबर 2006 MDLZ Employee stock option (right to buy) Common Stock (520) $31.00 12 जून 2011 520 निपटाया हुआ
23 अक्टूबर 2006 MDLZ Employee stock option (right to buy) Common Stock (1040) $31.00 12 जून 2011 1040 निपटाया हुआ
17 अक्टूबर 2006 MDLZ Employee stock option (right to buy) Common Stock (1600) $31.00 12 जून 2011 1600 निपटाया हुआ
16 अक्टूबर 2006 MDLZ Employee stock option (right to buy) Common Stock (1330) $31.00 12 जून 2011 1330 निपटाया हुआ
12 अक्टूबर 2006 MDLZ Employee stock option (right to buy) Common Stock (920) $31.00 12 जून 2011 920 निपटाया हुआ
11 अक्टूबर 2006 MDLZ Employee stock option (right to buy) Common Stock (1440) $31.00 12 जून 2011 1440 निपटाया हुआ
5 अक्टूबर 2006 MDLZ Employee stock option (right to buy) Common Stock (490) $31.00 12 जून 2011 490 निपटाया हुआ
29 सितमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (200) $31.00 12 जून 2011 200 निपटाया हुआ
27 सितमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (1060) $31.00 12 जून 2011 1060 निपटाया हुआ
26 सितमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (6370) $31.00 12 जून 2011 6370 निपटाया हुआ
25 सितमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (1350) $31.00 12 जून 2011 1350 निपटाया हुआ
21 सितमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (250) $31.00 12 जून 2011 250 निपटाया हुआ
15 सितमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (100) $31.00 12 जून 2011 100 निपटाया हुआ
12 सितमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (270) $31.00 12 जून 2011 270 निपटाया हुआ
1 सितमबर 2006 MDLZ Employee stock option (right to buy) Common Stock (330) $31.00 12 जून 2011 330 निपटाया हुआ
31 अगस्त 2006 MDLZ Employee stock option (right to buy) Common Stock (1370) $31.00 12 जून 2011 1370 निपटाया हुआ
30 अगस्त 2006 MDLZ Employee stock option (right to buy) Common Stock (3330) $31.00 12 जून 2011 3330 निपटाया हुआ
28 अगस्त 2006 MDLZ Employee stock option (right to buy) Common Stock (100) $31.00 12 जून 2011 100 निपटाया हुआ
14 अगस्त 2006 MDLZ Employee stock option (right to buy) Common Stock (680) $31.00 12 जून 2011 680 निपटाया हुआ
8 अगस्त 2006 MDLZ Employee stock option (right to buy) Common Stock (250) $31.00 12 जून 2011 250 निपटाया हुआ
4 अगस्त 2006 MDLZ Employee stock option (right to buy) Common Stock (330) $31.00 12 जून 2011 330 निपटाया हुआ
26 जुलाई 2006 MDLZ Employee stock option (right to buy) Common Stock (260) $31.00 12 जून 2011 260 निपटाया हुआ
25 जुलाई 2006 MDLZ Employee stock option (right to buy) Common Stock (540) $31.00 12 जून 2011 540 निपटाया हुआ
1 जून 2006 MDLZ Employee stock option (right to buy) Common Stock (250) $31.00 12 जून 2011 250 निपटाया हुआ
30 मई 2006 MDLZ Employee stock option (right to buy) Common Stock (540) $31.00 12 जून 2011 540 निपटाया हुआ
26 मई 2006 MDLZ Employee stock option (right to buy) Common Stock (890) $31.00 12 जून 2011 890 निपटाया हुआ
24 मई 2006 MDLZ Employee stock option (right to buy) Common Stock (1525) $31.00 12 जून 2011 1525 निपटाया हुआ
19 मई 2006 MDLZ Employee stock option (right to buy) Common Stock (280) $31.00 12 जून 2011 280 निपटाया हुआ
2 मई 2006 MDLZ Employee stock option (right to buy) Class A Common Stock (1850) $31.00 12 जून 2011 1850 निपटाया हुआ
6 जुलाई 2005 MDLZ Employee stock option (right to buy) Class A Common (100) $31.00 12 जून 2011 100 निपटाया हुआ
30 जून 2005 MDLZ Employee stock option (right to buy) Class A Common (620) $31.00 12 जून 2011 620 निपटाया हुआ
23 जून 2005 MDLZ Employee stock option (right to buy) Class A Common (1880) $31.00 12 जून 2011 1880 निपटाया हुआ
22 जून 2005 MDLZ Employee stock option (right to buy) Class A Common (1180) $31.00 12 जून 2011 1180 निपटाया हुआ
20 जून 2005 MDLZ Employee stock option (right to buy) Class A Common (810) $31.00 12 जून 2011 810 निपटाया हुआ
10 जून 2005 MDLZ Employee stock option (right to buy) Class A Common (190) $31.00 12 जून 2011 190 निपटाया हुआ
31 मई 2005 MDLZ Employee stock option (right to buy) Class A Common (5020) $31.00 12 जून 2011 5020 निपटाया हुआ
26 मई 2005 MDLZ Employee stock option (right to buy) Class A Common (740) $31.00 12 जून 2011 740 निपटाया हुआ
25 मई 2005 MDLZ Employee stock option (right to buy) Class A Common (410) $31.00 12 जून 2011 410 निपटाया हुआ
19 मई 2005 MDLZ Employee stock option (right to buy) Class A Common (880) $31.00 12 जून 2011 880 निपटाया हुआ
16 मई 2005 MDLZ Employee stock option (right to buy) Class A Common (820) $31.00 12 जून 2011 820 निपटाया हुआ
9 मई 2005 MDLZ Employee stock option (right to buy) Class A Common (100) $31.00 12 जून 2011 100 निपटाया हुआ
2 मई 2005 MDLZ Employee stock option (right to buy) Class A Common (280) $31.00 12 जून 2011 280 निपटाया हुआ
29 अप्रैल 2005 MDLZ Employee stock option (right to buy) Class A Common (970) $31.00 12 जून 2011 970 निपटाया हुआ
14 मार्च 2005 MDLZ Employee stock option (right to buy) Class A Common (1280) $31.00 12 जून 2011 1280 निपटाया हुआ
11 मार्च 2005 MDLZ Employee stock option (right to buy) Class A Common (350) $31.00 12 जून 2011 350 निपटाया हुआ
7 मार्च 2005 MDLZ Employee stock option (right to buy) Class A Common (100) $31.00 12 जून 2011 100 निपटाया हुआ
28 फ़रवरी 2005 MDLZ Employee stock option (right to buy) Class A Common (390) $31.00 12 जून 2011 390 निपटाया हुआ
25 फ़रवरी 2005 MDLZ Employee stock option (right to buy) Class A Common (2910) $31.00 12 जून 2011 2910 निपटाया हुआ
24 फ़रवरी 2005 MDLZ Employee stock option (right to buy) Class A Common (200) $31.00 12 जून 2011 200 निपटाया हुआ
22 फ़रवरी 2005 MDLZ Employee stock option (right to buy) Class A Common (1430) $31.00 12 जून 2011 1430 निपटाया हुआ
18 फ़रवरी 2005 MDLZ Employee stock option (right to buy Class A Common (300) $31.00 12 जून 2011 300 निपटाया हुआ
9 फ़रवरी 2005 MDLZ Empoyee stock option (right to buy) Class A Common (260) $31.00 12 जून 2011 260 निपटाया हुआ
8 फ़रवरी 2005 MDLZ Employee stock option (right to buy) Class A Common (1130) $31.00 12 जून 2011 1130 निपटाया हुआ
2 फ़रवरी 2005 MDLZ Employee stock option (right to buy) Class A Common (650) $31.00 12 जून 2011 650 निपटाया हुआ
24 जनवरी 2005 MDLZ Employee stock option (right to buy) Class A Common (200) $31.00 12 जून 2011 200 निपटाया हुआ
19 जनवरी 2005 MDLZ Employee stock option (right to buy) Class A Common (770) $31.00 12 जून 2011 770 निपटाया हुआ

157 लेन-देन में से नवीनतम 100 दिखा रहा है

अभ्यास/रूपांतरण मूल्य लागू न होने पर खाली होता है (जैसे, RSU)।

प्रारंभिक स्वामित्व (फॉर्म 3) 1 होल्डिंग

SEC फॉर्म 3 के अनुसार, अंदरूनी सूत्र बनने पर पहली बार रखी गई प्रतिभूतियां।

दिनांक टिकर सुरक्षा शेयर स्वामित्व
7 मार्च 2008 MO Common Stock 150 सीधा

मुआवजा (DEF 14A)

प्रॉक्सी स्टेटमेंट (DEF 14A) से नाम से मिलान किया गया — फाइलिंग के विरुद्ध सत्यापित करें।

MO

वित्तीय वर्ष वेतन बोनस स्टॉक पुरस्कार ऑप्शन पुरस्कार गैर-इक्विटी प्रोत्साहन पेंशन परिवर्तन अन्य कुल
2019 $871667 $2200099 $2456241 $104052 $9373759
2014 $1241667 $5250206 $2629203 $249914 $12320990
2011 $787117 $1650208 $925088 $150208 $4612621

आंकड़े कंपनी के प्रॉक्सी स्टेटमेंट (DEF 14A) के सारांश मुआवजा तालिका से हैं। मुआवजा कोई सिफारिश नहीं है।